Reduction of oxidative stress in chronic kidney disease does not increase circulating α-klotho concentrations

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Adema, Aaltje Y ^a   van Ittersum, Frans J ^a   Hoenderop, Joost G ^b   de Borst, Martin H ^c   Nanayakkara, Prabath W ^a   Ter Wee, Piet M ^a   Heijboer, Annemieke C ^a   Vervloet, Marc G ^a,d   Bindels, R ^b   Hillebrands, J L ^c   Navis, G J ^c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIOXIDANT; BETA GLUCURONIDASE; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PRAVASTATIN;

ADULT; AGED; BLOOD; CONTROLLED STUDY; DRUG EFFECTS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RENAL INSUFFICIENCY, CHRONIC; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; YOUNG ADULT;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; BIOMARKERS; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; GLUCURONIDASE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PRAVASTATIN; RENAL INSUFFICIENCY, CHRONIC; RENIN-ANGIOTENSIN SYSTEM; VITAMIN E; YOUNG ADULT;

EID: 85013101111     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0144121     Document Type: Article

References (36)

1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. Journal of the American Society of Nephrology: JASN. 1998; 9(12 Suppl):S16-23. PMID: 11443763
2. Olauson H, Vervloet MG, Cozzolino M, Massy ZA, Urena Torres P, Larsson TE. New insights into the FGF23-Klotho axis. Seminars in nephrology. 2014; 34(6):586-97. doi: 10.1016/j.semnephrol.2014.09. 005 PMID: 25498378
3. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011; 377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3 PMID: 21663949
4. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997; 390(6655):45-51. PMID: 9363890
5. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, et al. Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010; 24(9):3438-50.
6. Kuro-o M. Klotho as a regulator of oxidative stress and senescence. Biological chemistry. 2008; 389 (3):233-41. doi: 10.1515/BC.2008.028 PMID: 18177265
7. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, et al. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension. 2002; 39(4):838-43. PMID: 11967236
8. Sun CY, Chang SC, Wu MS. Suppression of Klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation. Kidney international. 2012; 81(7):640-50. doi: 10.1038/ki.2011.445 PMID: 22237753
9. Yoon HE, Ghee JY, Piao S, Song JH, Han DH, Kim S, et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2011; 26(3):800-13.
10. Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, et al. Circulating alpha-klotho levels in CKD and relationship to progression. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2013; 61(6):899-909.
11. Semba RD, Cappola AR, Sun K, Bandinelli S, Dalal M, Crasto C, et al. Plasma klotho and cardiovascular disease in adults. Journal of the American Geriatrics Society. 2011; 59(9):1596-601. doi: 10.1111/j. 1532-5415.2011.03558.x PMID: 21883107
12. Kitagawa M, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, et al. A decreased level of serum soluble Klotho is an independent biomarker associated with arterial stiffness in patients with chronic kidney disease. PloS one. 2013; 8(2):e56695. doi: 10.1371/journal.pone.0056695 PMID: 23431388
13. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, et al. Klotho deficiency causes vascular calcification in chronic kidney disease. Journal of the American Society of Nephrology: JASN. 2011; 22 (1):124-36. doi: 10.1681/ASN.2009121311 PMID: 21115613
14. Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Molecular endocrinology (Baltimore, Md). 2003; 17(12):2393-403.
15. Forster RE, Jurutka PW, Hsieh JC, Haussler CA, Lowmiller CL, Kaneko I, et al. Vitamin D receptor controls expression of the anti-aging klotho gene in mouse and human renal cells. Biochemical and biophysical research communications. 2011; 414(3):557-62. doi: 10.1016/j.bbrc.2011.09.117 PMID: 21982773
16. Haussler MR, Haussler CA, Whitfield GK, Hsieh JC, Thompson PD, Barthel TK, et al. The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the "Fountain of Youth" to mediate healthful aging. The Journal of steroid biochemistry and molecular biology. 2010; 121(1-2):88-97. doi: 10.1016/j.jsbmb.2010.03.019 PMID: 20227497
17. Zhang H, Li Y, Fan Y, Wu J, Zhao B, Guan Y, et al. Klotho is a target gene of PPAR-gamma. Kidney international. 2008; 74(6):732-9. doi: 10.1038/ki.2008.244 PMID: 18547997
18. Zhang R, Zheng F. PPAR-gamma and aging: one link through klotho? Kidney international. 2008; 74 (6):702-4. doi: 10.1038/ki.2008.382 PMID: 18756295
19. Yamagishi T, Saito Y, Nakamura T, Takeda S, Kanai H, Sumino H, et al. Troglitazone improves endothelial function and augments renal klotho mRNA expression in Otsuka Long-Evans Tokushima Fatty (OLETF) rats with multiple atherogenic risk factors. Hypertension research: official journal of the Japanese Society of Hypertension. 2001; 24(6):705-9.
20. Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. Journal of the American Society of Nephrology: JASN. 2009; 20(11):2380-8. doi: 10.1681/ASN.2008111138 PMID: 19797472
21. Saito K, Ishizaka N, Mitani H, Ohno M, Nagai R. Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS letters. 2003; 551(1-3):58-62. PMID: 12965205
22. Mitobe M, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, Nihei H. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Experimental nephrology. 2005; 101(2):e67-74. PMID: 15976510
23. Kuwahara N, Sasaki S, Kobara M, Nakata T, Tatsumi T, Irie H, et al. HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. International journal of cardiology. 2008; 123(2):84-90. PMID: 17434618
24. Narumiya H, Sasaki S, Kuwahara N, Irie H, Kusaba T, Kameyama H, et al. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovascular research. 2004; 64(2):331-6. PMID: 15485693
25. Nanayakkara PW, van Guldener C, ter Wee PM, Scheffer PG, van Ittersum FJ, Twisk JW, et al. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study. Archives of internal medicine. 2007; 167(12):1262-70. PMID: 17592099
26. Heijboer AC, Blankenstein MA, Hoenderop J, de Borst MH, Vervloet MG. Laboratory aspects of circulating alpha-Klotho. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 2013; 28(9):2283-7.
27. Heijboer AC, Levitus M, Vervloet MG, Lips P, ter Wee PM, Dijstelbloem HM, et al. Determination of fibroblast growth factor 23. Annals of clinical biochemistry. 2009; 46(Pt 4):338-40. doi: 10.1258/acb. 2009.009066 PMID: 19564163
28. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013; 3:1-150.
29. Aizawa H, Saito Y, Nakamura T, Inoue M, Imanari T, Ohyama Y, et al. Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochemical and biophysical research communications. 1998; 249(3):865-71. PMID: 9731228
30. Nagai T, Yamada K, Kim HC, Kim YS, Noda Y, Imura A, et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2003; 17(1):50-2.
31. Yoon HE, Lim SW, Piao SG, Song JH, Kim J, Yang CW. Statin Upregulates the Expression of Klotho, an Anti-Aging Gene, in Experimental Cyclosporine Nephropathy. Nephron Experimental nephrology. 2012; 120(4):e123-e33. doi: 10.1159/000342117 PMID: 22986347
32. Tamura A, Watanabe T, Nasu M. Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients. Circulation journal: official journal of the Japanese Circulation Society. 2003; 67(10):816-20.
33. Moon GJ, Kim SJ, Cho YH, Ryoo S, Bang OY. Antioxidant effects of statins in patients with atherosclerotic cerebrovascular disease. Journal of clinical neurology (Seoul, Korea). 2014; 10(2):140-7.
34. Giray B, Kan E, Bali M, Hincal F, Basaran N. The effect of vitamin E supplementation on antioxidant enzyme activities and lipid peroxidation levels in hemodialysis patients. Clinica chimica acta; international journal of clinical chemistry. 2003; 338(1-2):91-8. PMID: 14637272
35. Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L. Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria. Clinical journal of the American Society of Nephrology: CJASN. 2013; 8(11):1899-905. doi: 10.2215/CJN.02700313 PMID: 23929932
36. Pedersen L, Pedersen SM, Brasen CL, Rasmussen LM. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. Clinical biochemistry. 2013; 46(12):1079-83. doi: 10.1016/j.clinbiochem.2013.05.046 PMID: 23707222